The American Journal of Medicine
Volume 116, Issue 7 , Pages 474-477 , 1 April 2004

Health care lobbying in the United States

  • Steven H Landers, MD

      Affiliations

    • Department of Family Medicine, University Hospitals and Case Western Reserve University (SHL), Cleveland, Ohio, USA
    • ,
  • Ashwini R Sehgal, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Dr. Sehgal at the Division of Nephrology, MetroHealth Medical Center, 2500 MetroHealth Drive, Cleveland, Ohio 44109, USA
    • Center for Reducing Health Disparities, Center for Health Care Research and Policy, Division of Nephrology, Departments of Medicine, Biomedical Ethics, and Epidemiology and Biostatistics, MetroHealth Medical Center and Case Western Reserve University (ARS), Cleveland, Ohio, USA

Received 21 May 2003 ,Revised 20 October 2003 ,Accepted 20 October 2003.

  • Image Result

    Trends in health lobbying expenditures by different types of groups from 1997 to 2000 The rate of increase in expenditures was significantly greater (P <0.05) among pharmaceutical/health product compa

    Trends in health lobbying expenditures by different types of groups from 1997 to 2000 The rate of increase in expenditures was significantly greater (P <0.05) among pharmaceutical/health product companies and hospitals/nursing homes (solid lines) compared with other organizations (dotted lines).

PII: S0002-9343(03)00803-9

doi: 10.1016/j.amjmed.2003.10.037

The American Journal of Medicine
Volume 116, Issue 7 , Pages 474-477 , 1 April 2004

Article Tools

* Image Usage & Resolution